436 related articles for article (PubMed ID: 15280678)
1. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
[TBL] [Abstract][Full Text] [Related]
2. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
[TBL] [Abstract][Full Text] [Related]
3. The flow cytometric crossmatch and early renal transplant loss.
Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J
Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD
Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
[TBL] [Abstract][Full Text] [Related]
6. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation.
Takakura K; Kiuchi T; Kasahara M; Uryuhara K; Uemoto S; Inomata Y; Tanaka K
Clin Transplant; 2001 Oct; 15(5):309-16. PubMed ID: 11678956
[TBL] [Abstract][Full Text] [Related]
9. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
[TBL] [Abstract][Full Text] [Related]
10. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
ten Hoor GM; Coopmans M; Allebes WA
Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
[TBL] [Abstract][Full Text] [Related]
11. Is positive flow cytometric cross-match a risk factor for early cadaveric kidney graft dysfunction?
Piatosa B; Rubik J; Grenda R
Transplant Proc; 2006; 38(1):53-5. PubMed ID: 16504662
[TBL] [Abstract][Full Text] [Related]
12. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
[TBL] [Abstract][Full Text] [Related]
13. The impact of donor-specific antibodies on graft outcome in pediatric renal transplantation from deceased donors.
Piątosa B; Kwiatkowska A; Rubik J; Jarmużek W; Kluge P; Grenda R
Ann Transplant; 2011; 16(4):32-9. PubMed ID: 22210419
[TBL] [Abstract][Full Text] [Related]
14. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
[TBL] [Abstract][Full Text] [Related]
15. Flow cross-matching identifies patients at risk for postoperative elaboration of cytotoxic antibodies.
Kimball P; Rhodes C; King A; Fisher R; Ham J; Posner M
Transplantation; 1998 Feb; 65(3):444-6. PubMed ID: 9484770
[TBL] [Abstract][Full Text] [Related]
16. The value of flow cytometric crossmatch in cardiac transplantation.
Shenton BK; Bal W; Bell AE; Bookless B; Corris P; Dark JH
Transpl Int; 1994; 7 Suppl 1():S359-62. PubMed ID: 11271251
[TBL] [Abstract][Full Text] [Related]
17. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.
Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM
Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980
[TBL] [Abstract][Full Text] [Related]
18. A retrospective flow cytometric crossmatch study in transplant recipients with autoreactive lymphocytotoxic antibodies.
Martin S; Davies MS; Robson AJ
Transpl Int; 1994; 7 Suppl 1():S527-31. PubMed ID: 11271299
[TBL] [Abstract][Full Text] [Related]
19. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
[TBL] [Abstract][Full Text] [Related]
20. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]